• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

GE brings new vision to light

Article

It’s not a reorganization, according to executives at GE Medical Systems. It’s more like a new strategy or vision for guiding the company’s $8 billion healthcare business. The core of this strategy is to create three dedicated

It’s not a reorganization, according to executives at GE Medical Systems. It’s more like a new strategy or vision for guiding the company’s $8 billion healthcare business. The core of this strategy is to create three dedicated organizations focused on services, technology, and information technology.

The services organization addresses the clinical, operational, and financial needs of healthcare: namely asset, business, clinical, IT, and financial services. The technology organization covers the more traditional aspects of medical imaging, such as CT, MRI, and ultrasound. The third piece of the pie, information technologies, was first described in September 2000 and manages clinical information and images. The new vision includes no reshuffling of staff, just a change in the way GE does business.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.